J&J Unit Sues Over Monistat ANDA
In a complaint filed Friday in the U.S. District Court for the District of Delaware, McNeil-PPC alleged that Perrigo’s abbreviated new drug application, filed with the U.S. Food and Drug Administration earlier this year, seeks to market a product that will infringe McNeil-PPC’s patent before it expires.
The patent-in-suit, U.S. Patent No. 6,135,635, is titled “Methods and kits for treating vulvovaginal...
To view the full article, register now.